Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis. (Record no. 27342372)

MARC details
000 -LEADER
fixed length control field 01572 a2200433 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517162724.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201807s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1439-7609
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1080/14397595.2017.1337056
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Tanaka, Yoshiya
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20180705
245 00 - TITLE STATEMENT
Title Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Modern rheumatology
Date of publication, distribution, etc. Jan 2018
300 ## - PHYSICAL DESCRIPTION
Extent 58-65 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antirheumatic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Arthritis, Rheumatoid
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Chemokine CX3CL1
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Takeuchi, Tsutomu
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Umehara, Hisanori
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nanki, Toshihiro
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Yasuda, Nobuyuki
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tago, Fumitoshi
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kawakubo, Makoto
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kitahara, Yasumi
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hojo, Seiichiro
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kawano, Tetsu
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Imai, Toshio
773 0# - HOST ITEM ENTRY
Title Modern rheumatology
Related parts vol. 28
-- no. 1
-- p. 58-65
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1080/14397595.2017.1337056">https://doi.org/10.1080/14397595.2017.1337056</a>
Public note Available from publisher's website

No items available.